Project Orbis is an initiative launched in 2019 by the Oncology Centre of Excellence at the FDA (US Food and Drug Administration). The goal of the initiative is to leverage the existing scientific and regulatory partnerships between international regulatory authorities to provide a framework for concurrent submission and review and facilitate faster patient access to innovative cancer therapies with a high medical need across multiple countries.

In this webinar Claudia Reichle provides a closer look at Project Orbis and discusses what you should think about if you are offered the possibility to take part.


Claudia Reichle


You don't have to go it alone!

Our experienced team has been there before, and we're ready to guide you through the unknown. Share your challenges with us, and together, we'll create a plan to efficiently reach your milestones and turn your vision into reality.

Building Better Biotechs

This field is for validation purposes and should be left unchanged.